Twist Bioscience (TWST) Cash from Operations (2017 - 2026)

Twist Bioscience (TWST) has reported Cash from Operations for 10 consecutive years, with 17559000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Operations fell 35.21% year-over-year to 17559000.0; the TTM figure through Mar 2026 stood at 55587000.0 (up 0.94% YoY), while the FY2025 annual figure was 47628000.0, up 25.69% from the prior year.
• Cash from Operations improved to 17559000.0 in Q1 2026 per TWST's latest filing, from 24814000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 1267000.0 in Q3 2022 and bottomed at 54070000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 22017705.88 across 5 years, with a median of 20704000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Operations jumped 96.36% — and 2023, when it sank 1534.1%.
• Twist Bioscience's Cash from Operations stood at 54070000.0 in 2022, then soared by 57.51% to 22973000.0 in 2023, then grew by 6.73% to 21428000.0 in 2024, then fell by 15.8% to 24814000.0 in 2025, then gained by 29.24% to 17559000.0 in 2026.
• Business Quant data shows TWST's Cash from Operations at 17559000.0 in Q1 2026, 24814000.0 in Q4 2025, and 11814000.0 in Q3 2025.